Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.95p
   
  • Change Today:
      0.28p
  • 52 Week High: 7.65p
  • 52 Week Low: 1.23p
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 40,674,235
  • Market Cap: £23.07m
  • Beta: 1.88

Regulatory News

Business Update 21-Nov-2024 07:00 RNS
Q3 Trading Update 29-Oct-2024 07:00 RNS
Results from Phase 3 paediatric study 25-Sep-2024 07:00 RNS
Interim results 04-Sep-2024 07:00 RNS
ACCRUFeR® Approved by Health Canada 27-Aug-2024 07:00 RNS
Notice of interim results 14-Aug-2024 07:00 RNS
Unaudited Q2 2024 Trading Update 24-Jul-2024 07:01 RNS
Directorate Change 24-Jul-2024 07:00 RNS
$5.7m Milestone Monetization Agreement with AOP 03-Jul-2024 07:00 RNS
Results of 2024 Annual General Meeting 20-Jun-2024 16:25 RNS
New Drug Application for Accrufer® in South... 28-May-2024 07:00 RNS
Audited results for the year ended 31 Dec 2023 10-May-2024 15:30 RNS
Business Update for Q1 2024 30-Apr-2024 07:00 RNS
Notice of Results 16-Apr-2024 07:00 RNS
Unaudited Full Year Trading Update 21-Feb-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 2.95p
Change Today 0.28p
% Change 10.28 %
52 Week High 7.65p
52 Week Low 1.23p
Volume 40,674,235
Shares Issued 782.06m
Market Cap £23.07m
Beta 1.88

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.63% below the market average34.63% below the market average34.63% below the market average34.63% below the market average34.63% below the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Price Trend
30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average30.96% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Income Not Available
Growth
64.44% above the market average64.44% above the market average64.44% above the market average64.44% above the market average64.44% above the market average
70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average70.59% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:30 50,000 @ 2.95p
16:25 500,000 @ 3.23p
16:24 250,000 @ 2.90p
16:17 33,878 @ 2.94p
16:16 15,000 @ 2.94p

Top of Page